Literature DB >> 11587678

What is achieved by mammographic surveillance after breast conservation treatment for breast cancer?

F Ashkanani1, T Sarkar, G Needham, A Coldwells, A K Ah-See, F J Gilbert, A W Hutcheon, O Eremin, S D Heys.   

Abstract

BACKGROUND: After breast conservation surgery for breast cancer, patients are followed up by regular clinical examination and mammography, at intervals which vary according to local practice. However, the optimum interval remains unclear with current guidelines suggesting mammography should be carried out every 1 to 2 years. This study has investigated this aspect and, in particular, whether mammography or clinical examination or both allowed an early detection of recurrence of the disease in the conserved breast.
METHODS: A total of 695 patients who had undergone breast conservation surgery were identified from a database of prospectively recorded data during the period 1990 to 1995. Clinical examination and annual mammography were performed in accordance with local protocol. The results of clinical examination, mammography, and local recurrence rates were evaluated.
RESULTS: A total of 2,181 mammograms were undertaken in the 695 patients studied. Local recurrence of disease in the conserved breast occurred in 21 patients (3%), at a mean follow-up of 3.5 years. The first identification of tumor recurrence was by clinical examination in 11 patients with local recurrence, and by the surveillance mammography in the other 10 patients with local recurrence. Overall, mammography detected the local recurrence in 13 of 20 (65%) patients who underwent this examination. In the other patients, the recurrence was detected on clinical examination only. In addition, in 52 patients, mammography was falsely positive, giving a false positive rate of 2.3%. Contralateral cancers in the opposite breast were detected in 2 patients.
CONCLUSIONS: The detection of local disease after breast conservation surgery requires both clinical examination and mammography. In the context of our follow-up policy, in 52% of patients with local recurrence, this was first identified by clinical examination. Disease recurrence was identified in the other 48% of patients by mammographic surveillance. Overall, mammography will identify or confirm local recurrence in two thirds of women. However, in a small number of cases (2.3% in our series) mammography will give false positive results. New imaging modalities to assist in the diagnosis of local recurrence of disease after breast conservation surgery are required.

Entities:  

Mesh:

Year:  2001        PMID: 11587678     DOI: 10.1016/s0002-9610(01)00704-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis.

Authors:  C Weinstock; R Bigenwald; T Hochman; P Sun; S A Narod; E Warner
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

2.  Breast magnetic resonance imaging for surveillance of women with a personal history of breast cancer: outcomes stratified by interval between definitive surgery and surveillance MR imaging.

Authors:  Vivian Youngjean Park; Eun-Kyung Kim; Min Jung Kim; Hee Jung Moon; Jung Hyun Yoon
Journal:  BMC Cancer       Date:  2018-01-22       Impact factor: 4.430

3.  Screening women with a personal history of breast cancer: overview of the evidence on breast imaging surveillance.

Authors:  Nehmat Houssami; Nariya Cho
Journal:  Ultrasonography       Date:  2018-06-07

4.  Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial.

Authors:  Kinta Beaver; Debbie Tysver-Robinson; Malcolm Campbell; Mary Twomey; Susan Williamson; Andrew Hindley; Shabbir Susnerwala; Graham Dunn; Karen Luker
Journal:  BMJ       Date:  2009-01-14

5.  Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors.

Authors:  Chana Weinstock; Cristina Campassi; Olga Goloubeva; Kathleen Wooten; Susan Kesmodel; Emily Bellevance; Steven Feigenberg; Olga Ioffe; Katherine H R Tkaczuk
Journal:  Springerplus       Date:  2015-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.